Complete response induced by fotemustine given as single agent in a patient with primary central nervous system non-Hodgkin aggressive lymphoma relapsed after high-dose chemotherapy and autologous stem cell support

被引：4
|
作者：
Pennese, Elsa [1 ]
Vergine, Carolina [1 ]
Matera, Rosella [1 ]
Dargenio, Michela [1 ]
Forese, Pasquale [1 ]
Di Renzo, Nicola [1 ]
机构：
[1] Vito Fazzi Hosp, Hematol & Stem Cell Transplantat Unit, I-73100 Lecce, Italy
来源：
LEUKEMIA & LYMPHOMA | 2011年 / 52卷 / 11期
关键词：
PRIMARY CNS LYMPHOMAS; SALVAGE THERAPY; TEMOZOLOMIDE; CYTARABINE; ETOPOSIDE; TRIAL;
D O I：
10.3109/10428194.2011.585672
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2188 / 2189
页数：2
相关论文
共 48 条
  • [41] Long-Term Follow-Up of Tandem High-Dose Therapy with Autologous Stem Cell Support for Adults with High-Risk Age-Adjusted International Prognostic Index Aggressive non-Hodgkin Lymphomas: A GOELAMS Pilot Study
    Monjanel, Helene
    Deconinck, Eric
    Perrodeau, Elodie
    Gastinne, Thomas
    Delwail, Vincent
    Moreau, Anne
    Francois, Sylvie
    Berthou, Christian
    Gyan, Emmanuel
    Milpied, Noel
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (06) : 935 - 940
  • [42] Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience
    Ciochetto, Chiara
    Botto, Barbara
    Passera, Roberto
    Bello, Marilena
    Benevolo, Giulia
    Boccomini, Carola
    Castellino, Alessia
    Chiappella, Annalisa
    Freilone, Roberto
    Nicolosi, Maura
    Orsucci, Lorella
    Pecoraro, Clara
    Pregno, Patrizia
    Bisi, Gianni
    Vitolo, Umberto
    ANNALS OF HEMATOLOGY, 2018, 97 (09) : 1619 - 1626
  • [43] High-Dose Etoposide Plus Granulocyte Colony-Stimulating Factor as an Effective Chemomobilization Regimen for Autologous Stem Cell Transplantation in Patients with Non-Hodgkin Lymphoma Previously Treated with CHOP-based Chemotherapy: A Study from the Consortium for Improving Survival of Lymphoma
    Hyun, Shin Young
    Cheong, June-Won
    Kim, Soo-Jeong
    Min, Yoo Hong
    Yang, Deok-Hwan
    Ahn, Jae-Sook
    Lee, Won-Sik
    Ryoo, Hun-Mo
    Do, Young Rok
    Lee, Ho Sup
    Lee, Jae Hoon
    Oh, Sung Yong
    Suh, Cheolwon
    Yhim, Ho-Young
    Kim, Jin Seok
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (01) : 73 - 79
  • [44] B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL)
    Balzarotti, Monica
    Brusamolino, Ercole
    Angelucci, Emanuele
    Carella, Angelo Michele
    Vitolo, Umberto
    Russo, Eleonora
    Congiu, Angelagiovanna
    Gotti, Manuel
    Massidda, Stefania
    Botto, Barbara
    Annechini, Giorgia
    Spina, Michele
    Re, Alessandro
    Zilioli, Vittorio Ruggero
    Merli, Francesco
    Salvi, Flavia
    Stelitano, Caterina
    Bonfichi, Maurizio
    Rodari, Marcello
    Murru, Roberta
    Magagnoli, Massimo
    Anastasia, Antonella
    Mazza, Rita
    Giordano, Laura
    Santoro, Armando
    LEUKEMIA & LYMPHOMA, 2016, 57 (10) : 2375 - 2381
  • [45] Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma-a long-term follow-up study
    Kasenda, B.
    Schorb, E.
    Fritsch, K.
    Finke, J.
    Illerhaus, G.
    ANNALS OF ONCOLOGY, 2012, 23 (10) : 2670 - 2675
  • [46] Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma-a long-term follow-up study (vol 23, pg 2670, 2012)
    Kasenda, B.
    Schorb, E.
    Fritsch, K.
    Finke, J.
    Illerhaus, G.
    ANNALS OF ONCOLOGY, 2015, 26 (03) : 608 - 611
  • [47] Multicenter randomized phase III study of high-dose therapy with autologous stem cell transplantation versus observation for patients with newly diagnosed peripheral T-cell lymphoma who achieved complete metabolic response after induction therapy (JCOG2210, TRANSFER study)
    Kita, Ryosuke
    Shimada, Kazuyuki
    Machida, Ryunosuke
    Sekita, Tetsuya
    Sasaki, Keita
    Ishitsuka, Kenji
    Fukuda, Haruhiko
    Maruyama, Dai
    Munakata, Wataru
    Nagai, Hirokazu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 55 (02) : 183 - 188
  • [48] A prospective phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome
    Adhikari, Narayan
    Biswas, Ahitagni
    Gogia, Ajay
    Sahoo, Ranjit Kumar
    Garg, Ajay
    Nehra, Ashima
    Sharma, Mehar Chand
    Bhasker, Suman
    Singh, Manmohan
    Sreenivas, Vishnubhatla
    Chawla, Rohan
    Joshi, Garima
    Kumar, Lalit
    Chander, Subhash
    JOURNAL OF NEURO-ONCOLOGY, 2018, 139 (01) : 153 - 166
12345